My overnight blood glucose readings are 101 mg/dL and 72 mg/dL while I am taking insulin glargine (Lantus) 40 units daily; should I adjust my basal insulin dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Reduce Your Lantus Dose Immediately

Your overnight blood glucose readings of 101 mg/dL and 72 mg/dL on Lantus 40 units indicate you are experiencing nocturnal hypoglycemia and require an immediate dose reduction of 10–20% (reduce to 32–36 units). 1


Why This Dose Reduction Is Critical

  • Any blood glucose reading below 70 mg/dL constitutes hypoglycemia and mandates immediate insulin dose adjustment—your reading of 72 mg/dL is at the threshold and signals impending danger. 1

  • 78% of hospitalized patients on basal insulin experience nocturnal hypoglycemia (midnight–6 AM), yet 75% receive no dose adjustment before the next administration—this is a dangerous management gap you must avoid. 1

  • A fasting glucose below 100 mg/dL predicts next-day hypoglycemia, and your reading of 101 mg/dL combined with 72 mg/dL overnight confirms your basal insulin dose is excessive. 1

  • Recurrent hypoglycemia shifts glycemic thresholds lower, making future episodes harder to detect and increasing your risk of severe hypoglycemia with loss of consciousness. 1


Immediate Action Steps

Tonight's Dose Adjustment

  • Reduce your Lantus from 40 units to 32–36 units (a 10–20% reduction) starting with your next scheduled dose. 1

  • If you experience any glucose reading below 70 mg/dL, treat immediately with 15 grams of fast-acting carbohydrate (4 glucose tablets, 4 oz juice, or 1 tablespoon honey), recheck in 15 minutes, and repeat if needed. 1

Monitoring Requirements

  • Check your fasting blood glucose every morning during this adjustment period to guide further dose changes. 2

  • Set an alarm to check your blood glucose at 2–3 AM for the next 3–5 nights to ensure you are not experiencing undetected nocturnal hypoglycemia. 1

  • Record all glucose values to identify patterns and guide your healthcare provider's recommendations. 2


Ongoing Titration Protocol

If Fasting Glucose Remains 80–130 mg/dL

  • Maintain your current reduced dose (32–36 units) and continue daily fasting glucose monitoring. 2

  • Reassess after 3 days to ensure stability without hypoglycemia. 2

If Fasting Glucose Rises Above 140 mg/dL

  • Increase your Lantus dose by 2 units every 3 days until fasting glucose consistently falls within 80–130 mg/dL. 2

If Any Hypoglycemia Recurs

  • Reduce the dose by an additional 10–20% immediately and contact your healthcare provider. 1

Critical Safety Warnings

  • Never ignore a glucose reading below 70 mg/dL—a single unexplained episode warrants immediate dose reduction and provider notification. 1

  • Do not wait for multiple hypoglycemic episodes before adjusting your dose; each episode increases your risk of severe hypoglycemia and impairs your ability to detect future episodes. 1

  • Scrupulous avoidance of hypoglycemia for 2–3 weeks can reverse hypoglycemia unawareness if present, restoring your ability to recognize warning symptoms. 1

  • Always carry a source of fast-acting carbohydrate (glucose tablets, juice box) with you at all times. 2


When to Contact Your Healthcare Provider Urgently

  • Any glucose reading below 54 mg/dL (clinically significant hypoglycemia requiring urgent evaluation). 1

  • Recurrent hypoglycemia despite dose reduction (more than one episode below 70 mg/dL in a week). 1

  • Inability to detect hypoglycemia symptoms (hypoglycemia unawareness). 1

  • Fasting glucose persistently above 180 mg/dL after dose reduction, indicating need for careful re-titration. 2


Common Pitfalls to Avoid

  • Do not continue your current 40-unit dose hoping the hypoglycemia will resolve on its own—it will not, and you risk severe hypoglycemia with seizures or loss of consciousness. 1

  • Do not reduce your dose by only 1–2 units—a 10–20% reduction (4–8 units) is required to meaningfully reduce hypoglycemia risk. 1

  • Do not skip your basal insulin entirely in response to hypoglycemia, as this will cause rebound hyperglycemia; instead, reduce the dose appropriately. 1

  • Do not rely solely on correction insulin without adjusting your scheduled basal dose—the problem is your basal insulin, not your correction doses. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

How should I increase the dose of Lantus (insulin glargine) to improve its effect?
I have diabetes and my fasting blood glucose is lower than my 2 a.m. glucose; should I reduce my insulin glargine (Lantus) dose?
What is the equivalent dose of NPH (Neutral Protamine Hagedorn) insulin for 20 units of Lantus (insulin glargine)?
What is the recommended dose of Lantus (insulin glargine) for a patient with a current regimen of 20 units, undergoing an Esophagogastroduodenoscopy (EGD) and colonoscopy, who takes their usual dose the evening prior to the procedure?
Is Lantus (insulin glargine) safe to use during pregnancy?
What is the recommended suppressive antiviral regimen for genital herpes simplex virus type 2, including first‑line dosing, renal dose adjustments, and pregnancy considerations?
What is the role of pure antioxidant agents in the management of cirrhosis?
In a post‑menopausal woman with hormone‑receptor‑positive early breast cancer, how should I decide between a 5‑year and a 10‑year course of adjuvant endocrine therapy?
What is the recommended workup and treatment for new or worsening hallucinations, including evaluation for reversible medical, neurologic, psychiatric, and substance‑related causes and appropriate pharmacologic management?
Which of the following statements about viral hepatitis is correct? a) Hepatitis B virus (HBV) can be transmitted through contact with wounds b) HBV is not a cause of hepatocellular carcinoma (HCC) c) Hepatitis A virus (HAV) is a common cause of chronic liver disease d) Hepatitis E virus (HEV) can be transmitted through contaminated needles e) HBV viral load is estimated by measuring the polymerase
In a postmenopausal woman with early breast cancer, should adjuvant endocrine therapy be given based on whether the tumor is luminal (estrogen‑receptor‑positive and/or progesterone‑receptor‑positive) or non‑luminal (estrogen‑receptor‑negative/progesterone‑receptor‑negative, including triple‑negative or HER2‑enriched)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.